EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ibex Technologies's Enterprise Value is C$28.17 Mil.
Ibex Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2024 was C$1.78 Mil. Therefore, Ibex Technologies's EV-to-FCF for today is 15.84.
The historical rank and industry rank for Ibex Technologies's EV-to-FCF or its related term are showing as below:
TSXV:IBT'
s EV-to-FCF Range Over the Past 10 Years
Min: -56.55 Med: 2.63 Max: 195.43
Current: 15.84
During the past 13 years, the highest EV-to-FCF of Ibex Technologies was 195.43. The lowest was -56.55. And the median was 2.63.
TSXV:IBT's EV-to-FCF is ranked worse than 59.69% of 382
companies
in the Biotechnology industry
Industry Median: 8.405
vs TSXV:IBT: 15.84
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Ibex Technologies's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ibex Technologies's EV-to-FCF
For the Biotechnology subindustry, Ibex Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibex Technologies's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ibex Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ibex Technologies's EV-to-FCF falls into.
Ibex Technologies's current Enterprise Value is C$28.17 Mil.
Ibex Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ibex Technologies's PE Ratio for today is calculated as:
Ibex Technologies's share price for today is C$1.44.
Ibex Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.152.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ibex Technologies EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Ibex Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:IBT has been successfully added to your 